Article Details

Anavex Life Sciences Corp. (NASDAQ:AVXL) is Worth a Shot if You're a Risk-Capital Investor

Retrieved on: 2021-03-29 10:52:30

Tags for this article:

Click the tags to see associated articles and topics

Anavex Life Sciences Corp. (NASDAQ:AVXL) is Worth a Shot if You're a Risk-Capital Investor. View article details on hiswai:

Excerpt

Vanguard Group, Inc. (The) holds the second largest percentage of outstanding shares, with 4.17% or 2.9 Million shares worth $15.64 Million as of ...

Article found on: marketingsentinel.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo